Beutel Goodman & Co Ltd. purchased a new position in eMagin Corporation (NYSE:EMA – Free Report) in the 3rd quarter, HoldingsChannel reports. The fund purchased 256,268 shares of the company’s stock, valued at approximately $12,277,000.
A number of other large investors have also modified their holdings of EMA. TD Waterhouse Canada Inc. purchased a new position in eMagin in the third quarter valued at $223,735,000. The Manufacturers Life Insurance Company grew its stake in eMagin by 6.1% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,232,687 shares of the company’s stock worth $65,258,000 after purchasing an additional 71,020 shares in the last quarter. Cardinal Capital Management Inc. purchased a new stake in eMagin during the 3rd quarter worth about $10,613,000. Guardian Partners Inc. increased its holdings in eMagin by 4.9% during the 3rd quarter. Guardian Partners Inc. now owns 168,560 shares of the company’s stock worth $8,076,000 after purchasing an additional 7,850 shares during the period. Finally, Rathbones Group PLC increased its holdings in eMagin by 0.3% during the 1st quarter. Rathbones Group PLC now owns 58,900 shares of the company’s stock worth $3,043,000 after purchasing an additional 200 shares during the period.
eMagin Stock Performance
Shares of EMA opened at $50.55 on Tuesday. The firm’s fifty day simple moving average is $48.60 and its 200-day simple moving average is $51.18. eMagin Corporation has a twelve month low of $45.27 and a twelve month high of $55.49.
eMagin Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 30th will be issued a C$0.74 dividend. This represents a $2.96 annualized dividend and a yield of 5.9%. This is a boost from eMagin’s previous quarterly dividend of C$0.73. The ex-dividend date of this dividend is Friday, October 30th.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on EMA. Barclays decreased their price objective on eMagin from $53.00 to $50.00 and set an “equal weight” rating for the company in a research note on Monday, October 19th. Wall Street Zen lowered shares of eMagin from a “sell” rating to a “strong sell” rating in a research note on Saturday, October 31st. Finally, Weiss Ratings upgraded shares of eMagin from a “buy (b-)” rating to a “buy (b)” rating in a research note on Friday, October 23rd. One equities research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $50.00.
View Our Latest Research Report on EMA
About eMagin
Featured Articles
- Five stocks we like better than eMagin
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Want to see what other hedge funds are holding EMA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for eMagin Corporation (NYSE:EMA – Free Report).
Receive News & Ratings for eMagin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eMagin and related companies with MarketBeat.com's FREE daily email newsletter.
